Literature DB >> 15951812

Requirement for Notch1 signals at sequential early stages of intrathymic T cell development.

Joanne B Tan1, Ioana Visan, Julie S Yuan, Cynthia J Guidos.   

Abstract

Signaling through the transmembrane Notch1 receptor directs thymus-seeding progenitors (TSPs) to suppress their B cell potential and 'choose' the T cell fate. Present paradigms suggest that TSPs are contained in the multipotent early T lineage precursor (ETP) subset of thymocytes. However, we show here that the B cell potential of ETPs was not augmented in microenvironments that limited Notch1 activation. Furthermore, low-threshold Notch1 signals suppressed B cell production by TSPs before they reached the ETP stage. Notch1 signals of a higher threshold were needed to drive proliferation of ETPs and development into CD4(+)CD8(+) double-positive thymocytes. Thus, TSPs can be differentiated from all previously identified early T cell progenitors by their robust B cell potential and exquisite sensitivity to Notch1 signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951812     DOI: 10.1038/ni1217

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  80 in total

1.  The earliest intrathymic precursors of CD8α(+) thymic dendritic cells correspond to myeloid-type double-negative 1c cells.

Authors:  Hervé Luche; Laurence Ardouin; Pearline Teo; Peter See; Sandrine Henri; Miriam Merad; Florent Ginhoux; Bernard Malissen
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

Review 2.  Determining γδ versus αß T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

Review 3.  Forging T-Lymphocyte Identity: Intersecting Networks of Transcriptional Control.

Authors:  Ellen V Rothenberg; Jonas Ungerbäck; Ameya Champhekar
Journal:  Adv Immunol       Date:  2015-10-26       Impact factor: 3.543

4.  T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage.

Authors:  Laleh Talebian; Zhe Li; Yalin Guo; Justin Gaudet; Maren E Speck; Daisuke Sugiyama; Prabhjot Kaur; Warren S Pear; Ivan Maillard; Nancy A Speck
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

Review 5.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

6.  Notch-dependent T-lineage commitment occurs at extrathymic sites following bone marrow transplantation.

Authors:  Ivan Maillard; Benjamin A Schwarz; Arivazhagan Sambandam; Terry Fang; Olga Shestova; Lanwei Xu; Avinash Bhandoola; Warren S Pear
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

7.  Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1.

Authors:  Mari H Dallas; Barbara Varnum-Finney; Paul J Martin; Irwin D Bernstein
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

8.  Identification of a T lineage-committed progenitor in adult blood.

Authors:  Andreas Krueger; Harald von Boehmer
Journal:  Immunity       Date:  2007-01-11       Impact factor: 31.745

9.  Blockade of individual Notch ligands and receptors controls graft-versus-host disease.

Authors:  Ivy T Tran; Ashley R Sandy; Alexis J Carulli; Christen Ebens; Jooho Chung; Gloria T Shan; Vedran Radojcic; Ann Friedman; Thomas Gridley; Amy Shelton; Pavan Reddy; Linda C Samuelson; Minhong Yan; Christian W Siebel; Ivan Maillard
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

10.  CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus.

Authors:  Daniel A Zlotoff; Arivazhagan Sambandam; Theodore D Logan; J Jeremiah Bell; Benjamin A Schwarz; Avinash Bhandoola
Journal:  Blood       Date:  2009-12-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.